StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Avenue Therapeutics's price to book ratio was 2.5× on Oct 16, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.2× to 56.3×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 16, 20262.5×+1.9
2025Dec 31, 20250.6×−0.6
2024Dec 31, 20241.2×+0.1
2023Apr 28, 20231.2×−4.7
2022Oct 31, 20225.9×−35.3
2021Oct 29, 202141.2×+10.4
2020Dec 31, 202030.8×+17.4
2019Dec 31, 201913.4×−7.2
2018Dec 31, 201820.6×+19.1
2017Dec 29, 20171.5×–

More Avenue Therapeutics figures

See a number that looks wrong?